Sjogren's syndrome: An update on clinical, basic and diagnostic therapeutic aspects

Journal of Autoimmunity

Volumn 39, Issue 1-2, 2012, Pages 1-3

  Tzioufas, A G ^a   Vlachoyiannopoulos, P G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Autoantibodies; Autoimmunity; Biologic therapy; Epidemiology; Sjogren's syndrome

Indexed keywords

ARTICLE; CLINICAL PRACTICE; GREECE; HEALTH CARE; HUMAN; PHYSICIAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCIENTIST; SJOEGREN SYNDROME;

AUTOIMMUNITY; HUMANS; SJOGREN'S SYNDROME;

EID: 84861684753     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.01.006     Document Type: Article

References (81)

1. Alamanos Y., Tsifetaki N., Voulgari P.V., Venetsanopoulou A.I., Siozos C., Drosos A.A. Epidemiology of primary Sjogren's syndrome in north-west Greece, 1982-2003. Rheumatology (Oxford) 2006, 45:187-191.
2. Bowman S.J., Ibrahim G.H., Holmes G., Hamburger J., Ainsworth J.R. Estimating the prevalence among Caucasian women of primary Sjogren's syndrome in two general practices in Birmingham, UK. Scand J Rheum 2004, 33:39-43.
3. Dafni U.G., Tzioufas A.G., Staikos P., Skopouli F.N., Moutsopoulos H.M. Prevalence of Sjogren's syndrome in a closed rural community. Ann Rheum Dis 1997, 56:521-525.
4. Thomas E., Hay E.M., Hajeer A., Silman A.J. Sjogren's syndrome: a community-based study of prevalence and impact. Br J Rheum 1998, 37:1069-1076.
5. Youinou P., Haralampos M. Moutsopoulos: a lifetime in autoimmunity. J Autoimmun 2010, 35:171-175.
6. Drosos A.A., Skopouli F.N., Costopoulos J.S., Papadimitriou C.S., Moutsopoulos H.M. Cyclosporin A (CyA) in primary Sjogren's syndrome: a double blind study. Ann Rheum Dis 1986, 45:732-735.
7. Fauci A.S., Moutsopoulos H.M. Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and primary Sjogren's syndrome. Arthritis Rheum 1981, 24:577-583.
8. Fye K.H., Terasaki P.I., Moutsopoulos H., Daniels T.E., Michalski J.P., Talal N. Association of Sjogren's syndrome with HLA-B8. Arthritis Rheum 1976, 19:883-886.
9. Ioannidis J.P., Vassiliou V.A., Moutsopoulos H.M. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome. Arthritis Rheum 2002, 46:741-747.
10. Leroy J.P., Drosos A.A., Yiannopoulos D.I., Youinou P., Moutsopoulos H.M. Intravenous pulse cyclophosphamide therapy in myositis and Sjogren's syndrome. Arthritis Rheum 1990, 33:1579-1581.
11. Liakos D.A., Triantafyllopoulou A., Kapsogeorgou E.K., Moutsopoulos H.M. Autoimmune diseases: role of coxsackieviruses in their pathogenesis. Autoimmun Rev 2004, 3(Suppl 1):S71-S73.
12. Manoussakis M.N., Dimitriou I.D., Kapsogeorgou E.K., Xanthou G., Paikos S., Polihronis M., et al. Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjogren's syndrome. Arthritis Rheum 1999, 42:229-239.
13. Manoussakis M.N., Georgopoulou C., Zintzaras E., Spyropoulou M., Stavropoulou A., Skopouli F.N., et al. Sjogren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjogren's syndrome. Arthritis Rheum 2004, 50:882-891.
14. Moutsopoulos H.M. Sjogren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol 1994, 72:162-165.
15. Moutsopoulos H.M., Hooks J.J., Chan C.C., Dalavanga Y.A., Skopouli F.N., Detrick B. HLA-DR expression by labial minor salivary gland tissues in Sjogren's syndrome. Ann Rheum Dis 1986, 45:677-683.
16. Tzioufas A.G., Boumba D.S., Skopouli F.N., Moutsopoulos H.M. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjogren's syndrome. Arthritis Rheum 1996, 39:767-772.
17. Mackay I.R., Leskovsek N.V., Rose N.R. The odd couple: a fresh look at autoimmunity and immunodeficiency. J Autoimmun 2010, 35:199-205.
18. Manoussakis M.N., Spachidou M.P., Maratheftis C.I. Salivary epithelial cells from Sjogren's syndrome patients are highly sensitive to anoikis induced by TLR-3 ligation. J Autoimmun 2010, 35:212-218.
19. Manoussakis M.N., Kapsogeorgou E.K. The role of intrinsic epithelial activation in the pathogenesis of Sjogren's syndrome. J Autoimmun 2010, 35:219-224.
20. Mavragani C.P., Crow M.K. Activation of the type I interferon pathway in primary Sjogren's syndrome. J Autoimmun 2010, 35:225-231.
21. Miyagawa F., Gutermuth J., Zhang H., Katz S.I. The use of mouse models to better understand mechanisms of autoimmunity and tolerance. J Autoimmun 2010, 35:192-198.
22. Passam F.H., Qi J.C., Tanaka K., Matthaei K.I., Krilis S.A. In vivo modulation of angiogenesis by beta 2 glycoprotein I. J Autoimmun 2010, 35:232-240.
23. Roguedas A.M., Pers J.O., Lemasson G., Devauchelle V., Tobon G.J., Saraux A., et al. Memory B-cell aggregates in skin biopsy are diagnostic for primary Sjogren's syndrome. J Autoimmun 2010, 35:241-247.
24. Wiik A.S., Hoier-Madsen M., Forslid J., Charles P., Meyrowitsch J. Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells. J Autoimmun 2010, 35:276-290.
25. Tsuda M., Torgerson T.R., Selmi C., Gambineri E., Carneiro-Sampaio M., Mannurita S.C., et al. The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies. J Autoimmun 2010, 35:265-268.
26. Kapsogeorgou E.K., Manoussakis M.N. Salivary gland epithelial cells (SGEC): carriers of exquisite B7-2 (CD86) costimulatory molecules. J Autoimmun 2010, 35:188-191.
27. Routsias J.G., Tzioufas A.G. B-cell epitopes of the intracellular autoantigens Ro/SSA and La/SSB: tools to study the regulation of the autoimmune response. J Autoimmun 2010, 35:256-264.
28. Juran B.D., Lazaridis K.N. Update on the genetics and genomics of PBC. J Autoimmun 2010, 35:181-187.
29. Kontaki E., Boumpas D.T. Innate immunity in systemic lupus erythematosus: sensing endogenous nucleic acids. J Autoimmun 2010, 35:206-211.
30. Scheinecker C., Bonelli M., Smolen J.S. Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells. J Autoimmun 2010, 35:269-275.
31. Bernuzzi F., Fenoglio D., Battaglia F., Fravega M., Gershwin M.E., Indiveri F., et al. Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis. J Autoimmun 2010, 35:176-180.
32. Vlachoyiannopoulos P.G., Routsias J.G. A novel mechanism of thrombosis in antiphospholipid antibody syndrome. J Autoimmun 2010, 35:248-255.
33. Abbott A. Greek crisis spurs research reforms. Nature 2011, 475:13-14.
34. Rossi V., Delgado Aguilera R. No painless solution to Greece's dept crisis 2010, Catham House, UK.
35. Kentikelenis A., Karanikolos M., Papanicolas I., Basu S., McKee M., Stuckler D. Health effects of financial crisis: omens of a Greek tragedy. Lancet 2011, 378:1457-1458.
36. Berkun Y., Padeh S. Environmental factors and the geoepidemiology of juvenile idiopathic arthritis. Autoimmun Rev 2010, 9:A319-A324.
37. Bhat A., Naguwa S., Cheema G., Gershwin M.E. The epidemiology of transverse myelitis. Autoimmun Rev 2010, 9:A395-A399.
38. Biggioggero M., Meroni P.L. The geoepidemiology of the antiphospholipid antibody syndrome. Autoimmun Rev 2010, 9:A299-A304.
39. Borchers A.T., Naguwa S.M., Shoenfeld Y., Gershwin M.E. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 2010, 9:A277-A287.
40. Borchers A.T., Uibo R., Gershwin M.E. The geoepidemiology of type 1 diabetes. Autoimmun Rev 2010, 9:A355-A365.
41. Chen M., Kallenberg C.G. The environment, geoepidemiology and ANCA-associated vasculitides. Autoimmun Rev 2010, 9:A293-A298.
42. Deane S., Teuber S.S., Gershwin M.E. The geoepidemiology of immune thrombocytopenic purpura. Autoimmun Rev 2010, 9:A342-A349.
43. Ehrenfeld M. Geoepidemiology: the environment and spondyloarthropathies. Autoimmun Rev 2010, 9:A325-A329.
44. Hershko A.Y., Naparstek Y. Autoimmunity in the era of genomics and proteomics. Autoimmun Rev 2006, 5:230-233.
45. Lambert J.F., Nydegger U.E. Geoepidemiology of autoimmune hemolytic anemia. Autoimmun Rev 2010, 9:A350-A354.
46. Leung P.S., Shu S.A., Kenny T.P., Wu P.Y., Tao M.H. Development and validation of gene therapies in autoimmune diseases: epidemiology to animal models. Autoimmun Rev 2010, 9:A400-A405.
47. Lleo A., Invernizzi P., Gao B., Podda M., Gershwin M.E. Definition of human autoimmunity-autoantibodies versus autoimmune disease. Autoimmun Rev 2010, 9:A259-A266.
48. Logan I., Bowlus C.L. The geoepidemiology of autoimmune intestinal diseases. Autoimmun Rev 2010, 9:A372-A378.
49. Mackay I.R. Travels and travails of autoimmunity: a historical journey from discovery to rediscovery. Autoimmun Rev 2010, 9:A251-A258.
50. Mavragani C.P., Moutsopoulos H.M. The geoepidemiology of Sjogren's syndrome. Autoimmun Rev 2010, 9:A305-A310.
51. Meyer A., Levy Y. Chapter 33: geoepidemiology of myasthenia gravis. Autoimmun Rev 2010, 9:A383-A386.
52. Meyer N., Misery L. Geoepidemiologic considerations of auto-immune pemphigus. Autoimmun Rev 2010, 9:A379-A382.
53. Milo R., Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev 2010, 9:A387-A394.
54. Prieto S., Grau J.M. The geoepidemiology of autoimmune muscle disease. Autoimmun Rev 2010, 9:A330-A334.
55. Ranque B., Mouthon L. Geoepidemiology of systemic sclerosis. Autoimmun Rev 2010, 9:A311-A318.
56. Rubtsov A.V., Rubtsova K., Kappler J.W., Marrack P. Genetic and hormonal factors in female-biased autoimmunity. Autoimmun Rev 2010, 9:494-498.
57. Sands J., Tuscano J.M. Geoepidemiology and autoimmune manifestations of lymphoproliferative disorders. Autoimmun Rev 2010, 9:A335-A341.
58. Segelmark M., Hellmark T. Autoimmune kidney diseases. Autoimmun Rev 2010, 9:A366-A371.
59. Selmi C. The worldwide gradient of autoimmune conditions. Autoimmun Rev 2010, 9:A247-A250.
60. Selmi C., Tsuneyama K. Nutrition, geoepidemiology, and autoimmunity. Autoimmun Rev 2010, 9:A267-A270.
61. Stojanovich L. Stress and autoimmunity. Autoimmun Rev 2010, 9:A271-A276.
62. Tobon G.J., Youinou P., Saraux A. The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. Autoimmun Rev 2010, 9:A288-A292.
63. Tonutti E., Visentini D., Bizzaro N. Interpretative comments on autoantibody tests. Autoimmun Rev 2007, 6:341-346.
64. Arnson Y., Shoenfeld Y., Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010, 34:J258-J265.
65. Borchers A.T., Naguwa S.M., Keen C.L., Gershwin M.E. The implications of autoimmunity and pregnancy. J Autoimmun 2010, 34:J287-J299.
66. Brooks W.H., Le Dantec C., Pers J.O., Youinou P., Renaudineau Y. Epigenetics and autoimmunity. J Autoimmun 2010, 34:J207-J219.
67. Chandran V., Raychaudhuri S.P. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 2010, 34:J314-J321.
68. Chang C. The immune effects of naturally occurring and synthetic nanoparticles. J Autoimmun 2010, 34:J234-J246.
69. Chang C., Gershwin M.E. Drugs and autoimmunity-a contemporary review and mechanistic approach. J Autoimmun 2010, 34:J266-J275.
70. Chen M., Daha M.R., Kallenberg C.G. The complement system in systemic autoimmune disease. J Autoimmun 2010, 34:J276-J286.
71. Hemminki K., Li X., Sundquist J., Sundquist K. The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution. J Autoimmun 2010, 34:J307-J313.
72. Hoffmann M.H., Trembleau S., Muller S., Steiner G. Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential. J Autoimmun 2010, 34:J178-J206.
73. Invernizzi P. Geoepidemiology of autoimmune liver diseases. J Autoimmun 2010, 34:J300-J306.
74. Maverakis E., Miyamura Y., Bowen M.P., Correa G., Ono Y., Goodarzi H. Light, including ultraviolet. J Autoimmun 2010, 34:J247-J257.
75. Powell J.J., Faria N., Thomas-McKay E., Pele L.C. Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J Autoimmun 2010, 34:J226-J233.
76. Round J.L., O'Connell R.M., Mazmanian S.K. Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun 2010, 34:J220-J225.
77. Shapira Y., Agmon-Levin N., Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 2010, 34:J168-J177.
78. Shoenfeld Y., Selmi C., Zimlichman E., Gershwin M.E. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 2008, 31:325-330.
79. Tomer Y. Hepatitis C and interferon induced thyroiditis. J Autoimmun 2010, 34:J322-J326.
80. Youinou P., Pers J.O., Gershwin M.E., Shoenfeld Y. Geo-epidemiology and autoimmunity. J Autoimmun 2010, 34:J163-J167.
81. Zeki A.A., Schivo M., Chan A.L., Hardin K.A., Kenyon N.J., Albertson T.E., et al. Geoepidemiology of COPD and idiopathic pulmonary fibrosis. J Autoimmun 2010, 34:J327-J338.